STAA Q3 2020 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q3 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$47M+20.6% YoY

Gross Profit

$35M74.1% margin

Operating Income

$5M10.4% margin

Net Income

$4M8.3% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+33.8%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$235M

Total Liabilities

$48M

Stockholders' Equity

$186M

Cash & Equivalents

$128M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$39M	+20.6%
Gross Profit	$35M	$29M	+20.0%
Operating Income	$5M	$3M	+46.4%
Net Income	$4M	$2M	+63.0%

Revenue Segments

Implantable Collamer Lenses

$41M88%

Intraocular Lenses

$3M7%

Other Surgical Products

$2M5%